Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What’s the Evidence?

Schizophrenia is a disabling, chronic psychiatric disorder with a prevalence rate of 0.5–1% in the general population. Symptoms include positive (e.g., delusions, hallucinations), negative (e.g., blunted affect, social withdrawal), as well as cognitive symptoms (e.g., memory and attention problems)....

Descripción completa

Detalles Bibliográficos
Autores principales: Vingerhoets, Wilhelmina A. M., Bloemen, Oswald J. N., Bakker, Geor, van Amelsvoort, Therese A. M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849802/
https://www.ncbi.nlm.nih.gov/pubmed/24363646
http://dx.doi.org/10.3389/fpsyt.2013.00157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849802/
https://www.ncbi.nlm.nih.gov/pubmed/24363646
http://dx.doi.org/10.3389/fpsyt.2013.00157

Ejemplares similares